Jobie Budd

Jobie Budd

Auto-generated profile, based on publicly available information

Jobie Budd

London Centre for Nanotechnology, University College London, London, UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
JBJobie Budd
Jobie Budd
BMBenjamin S. Miller
Benjamin S. Miller
EMErin M. Manning
Erin M. Manning
VLVasileios Lampos
Vasileios Lampos
MZMengdie Zhuang
Mengdie Zhuang
RMRachel McKendry
Rachel McKendry

19 January 2023 in Nature Reviews Bioengineering
Verified
Journal Article
Open access
PDF file
JBJobie Budd
Jobie Budd
BMBenjamin S. Miller
Benjamin S. Miller
NWNicole E. Weckman
Nicole E. Weckman
DCDounia Cherkaoui
Dounia Cherkaoui
DHDa Huang
Da Huang
RMRachel McKendry
Rachel McKendry
The acceptability and feasibility of large-scale testing with lateral flow tests (LFTs) for clinical and public health purposes has been demonstrated during the COVID-19 pandemic. LFTs can detect analytes in a variety of samples, providing a rapid read-out, which allows self-testing and decentralized diagnosis. In this Review, we examine the changing LFT landscape with a focus on lessons learned from COVID-19. We discuss the implications of LFTs for decentralized testing of infectious diseases, including diseases of epidemic potential, the ‘silent pandemic’ of antimicrobial resistance, and other acute and chronic infections. Bioengineering approaches will play a key part in increasing the sensitivity and specificity of LFTs, improving sample preparation, incorporating nucleic acid amplification and detection, and enabling multiplexing, digital connection and green manufacturing, with the aim of creating the next generation of high-accuracy, easy-to-use, affordable and digitally connected LFTs. We conclude with recommendations, including the building of a global network of LFT research and development hubs to facilitate and strengthen future diagnostic resilience.

17 June 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
VTValérian Turbé
Valérian Turbé
CHCarina Herbst
Carina Herbst
TMThobeka Mngomezulu
Thobeka Mngomezulu
SMSepehr Meshkinfamfard
Sepehr Meshkinfamfard
NDNondumiso Dlamini
Nondumiso Dlamini
RMRachel McKendry
Rachel McKendry

7 February 2024 in Nature Machine Intelligence
Verified
Journal Article
Open access
PDF file
HCHarry Coppock
Harry Coppock
GNGeorge Nicholson
George Nicholson
IKIvan Kiskin
Ivan Kiskin
VKVasiliki Koutra
Vasiliki Koutra
KBKieran Baker
Kieran Baker
CHChris Holmes
Chris Holmes
Recent work has reported that respiratory audio-trained AI classifiers can accurately predict SARS-CoV-2 infection status. However, it has not yet been determined whether such model performance is driven by latent audio biomarkers with true causal links to SARS-CoV-2 infection or by confounding effects, such as recruitment bias, present in observational studies. Here we undertake a large-scale study of audio-based AI classifiers as part of the UK government’s pandemic response. We collect a dataset of audio recordings from 67,842 individuals, with linked metadata, of whom 23,514 had positive polymerase chain reaction tests for SARS-CoV-2. In an unadjusted analysis, similar to that in previous works, AI classifiers predict SARS-CoV-2 infection status with high accuracy (ROC–AUC = 0.846 [0.838–0.854]). However, after matching on measured confounders, such as self-reported symptoms, performance is much weaker (ROC–AUC = 0.619 [0.594–0.644]). Upon quantifying the utility of audio-based classifiers in practical settings, we find them to be outperformed by predictions on the basis of user-reported symptoms. We make best-practice recommendations for handling recruitment bias, and for assessing audio-based classifiers by their utility in relevant practical settings. Our work provides insights into the value of AI audio analysis and the importance of study design and treatment of confounders in AI-enabled diagnostics.

27 June 2024 in Scientific Data
Verified
Journal Article
Open access
PDF file
JBJobie Budd
Jobie Budd
KBKieran Baker
Kieran Baker
EKEmma Karoune
Emma Karoune
HCHarry Coppock
Harry Coppock
SPSelina Patel
Selina Patel
CHChris Holmes
Chris Holmes
The UK COVID-19 Vocal Audio Dataset is designed for the training and evaluation of machine learning models that classify SARS-CoV-2 infection status or associated respiratory symptoms using vocal audio. The UK Health Security Agency recruited voluntary participants through the national Test and Trace programme and the REACT-1 survey in England from March 2021 to March 2022, during dominant transmission of the Alpha and Delta SARS-CoV-2 variants and some Omicron variant sublineages. Audio recordings of volitional coughs, exhalations, and speech were collected in the ‘Speak up and help beat coronavirus’ digital survey alongside demographic, symptom and self-reported respiratory condition data. Digital survey submissions were linked to SARS-CoV-2 test results. The UK COVID-19 Vocal Audio Dataset represents the largest collection of SARS-CoV-2 PCR-referenced audio recordings to date. PCR results were linked to 70,565 of 72,999 participants and 24,105 of 25,706 positive cases. Respiratory symptoms were reported by 45.6% of participants. This dataset has additional potential uses for bioacoustics research, with 11.3% participants self-reporting asthma, and 27.2% with linked influenza PCR test results.